Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1902 participants.
Also called NCT02593149
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,902 participants
- Sponsor
- Pursuit Vascular, Inc.
- Registry
-
NCT02593149
-
- Main results
- Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02593149. Randomized; no masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2016-11 (actual). Results posted on 2019-02-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
- Condition
- End Stage Renal Disease (ESRD)
- Intervention (Device)
- ClearGuard HD End Cap
- Lead sponsor
- Pursuit Vascular, Inc.
- Collaborator
- Davita Clinical Research
Record details
- Record id
cardio:ct-nct02593149- Content hash
df48edfd19dcae1da475b177fa4fa22e6b446db089e6df22f2e98eca52e6a1fa